Skip to main content
Premium Trial:

Request an Annual Quote

Celera Signs on Emory, Van Andel as Subscribers to Database

NEW YORK, March 30 – Celera said Friday it has signed Emory University and the Van Andel Institute as subscribers to its database, and has extended its subscription agreement with the University of Texas Southwestern Medical Center to include the University of Texas M.D. Anderson Cancer Center in Houston.

Under the multi-year subscription agreements, researchers at Emory of Atlanta, the Van Andel Institute, a basic cancer research institute in Grand Rapids, Mich., and the M.D. Anderson Cancer Center will have full access to all of Celera’s databases through the Celera Discovery system, a web-based interface that includes software tools for searching and analyzing Celera’s proprietary databases.

The cost of the subscriptions were not disclosed, but Celera generally charges academic subscribers between $7,000 and $15,000 a year per scientist using the databases.

These new agreements add to Celera's list of over 30 subscribers to its database products, including 23 whose names have been publicly announced 

Celera’s other database subscribers include the University of California system, the Max Planck Society for Advancement of Science, the Karolinska Institutet, the University of Tokyo, Pfizer, Takeda, and American Home Products. 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.